Key result
Cardiac-specific overexpression of VEGF-B167 in mice led to significant left ventricular remodeling and heart failure by 14 months of age, with ejection fraction decreasing to 42% compared to 68% in wild-type mice.
Echocardiography and cardiovascular magnetic resonance imaging can effectively detect early progressive left ventricular remodeling in a transgenic mouse model of VEGF-B167 overexpression.
Answers are grounded in this paper and cite their sources.
VEGF-B167 overexpression induces heart failure in mice; leaves open its role in human remodeling and need for translational studies.
Cardiac‐specific overexpression of vascular endothelial growth factor ( VEGF )‐B 167 is known to induce left ventricular hypertrophy due to altered lipid metabolism, in which ceramides accumulate to the heart and cause mitochondrial damage. The aim of this study was to evaluate and compare different imaging methods to find the most sensitive way to diagnose at early stage the progressive left ventricular remodeling leading to heart failure. Echocardiography and cardiovascular magnetic resonance imaging were compared for imaging the hearts of transgenic mice with cardiac‐specific overexpression of VEGF ‐B 167 and wild‐type mice from 5 to 14 months of age at several time points. Disease progression was verified by molecular biology methods and histology. We showed that left ventricular remodeling is already ongoing at the age of 5 months in transgenic mice leading to heart failure by the age of 14 months. Measurements from echocardiography and cardiovascular magnetic resonance imaging revealed similar changes in cardiac structure and function in the transgenic mice. Changes in histology, gene expressions, and electrocardiography supported the progression of left ventricular hypertrophy. Longitudinal relaxation time in rotating frame (T 1 ρ ) in cardiovascular magnetic resonance imaging could be suitable for detecting severe fibrosis in the heart. We conclude that cardiac‐specific overexpression of VEGF ‐B 167 leads to left ventricular remodeling at early age and is a suitable model to study heart failure development with different imaging methods.
No takes yet. Share an insight, caveat, or question.
Lottonen‐Raikaslehto et al. (2017) studied Left ventricular hypertrophy and heart failure (n=31). Cardiac-specific overexpression of VEGF-B167 vs. Wild-type littermates was evaluated on Ejection fraction at 14 months measured by echocardiography (p=<0.001). Cardiac-specific overexpression of VEGF-B167 in mice led to significant left ventricular remodeling and heart failure by 14 months of age, with ejection fraction decreasing to 42% compared to 68% in wild-type mice.
Synapse has enriched 10 related papers. Consider them for comparative context: